|
|
Volumn 73, Issue 11, 2019, Pages 1362-1364
|
|
Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
a
a
a
a
a
a
a
a
a
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ICOSAPENTAENOIC ACID ETHYL ESTER;
LOW DENSITY LIPOPROTEIN;
PLACEBO;
TRIACYLGLYCEROL;
ADULT;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CHOLESTEROL BLOOD LEVEL;
COHORT ANALYSIS;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
HEART INFARCTION;
HUMAN;
HYPERTRIGLYCERIDEMIA;
LETTER;
LONGITUDINAL STUDY;
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL;
MAJOR CLINICAL STUDY;
OBSERVATIONAL STUDY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REGISTER;
RISK REDUCTION;
SECONDARY PREVENTION;
TRIACYLGLYCEROL BLOOD LEVEL;
MULTICENTER STUDY (TOPIC);
CORONARY ARTERY DISEASE;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 85062805206
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2019.01.016 Document Type: Letter |
|
Times cited : (33)
|
|
References (4)
|
